Special items: Ovarian Cancer and Us blog best viewed in Firefox

Friday, January 08, 2010

A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study

Jan 7th, 2009 abstract and full free access

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.